The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.
Infections as a major preventable cause of human cancer
Open accessAbstract
Abstract. Kuper H, Adami H‐O & Trichopoulos D (Harvard School of Public Health, Boston, MA, USA; Karolinska Institute, Stockholm, Sweden; University of Athens Medical School, Greece). Infections as a major preventable cause of human cancer (Internal Medicine in the 21st Century). J Intern Med 2000; 248: 171–183. Infections may be responsible for over 15% of all malignancies worldwide. Important mechanisms by which infectious agents may induce carcinogenesis include the production of chronic inflammation, the transformation of cells by insertion of oncogenes and inhibition of tumour suppressors, and the induction of immunosuppression. Common characteristics shared by infectious agents linked to malignancies are that they are persistent in the host, often highly prevalent in the host population and induce cancer after a long latency. The associations between a selection of infectious agents and malignancies are covered in detail.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Many cancers arise from sites of infection, chronic irritation and inflammation.”
From Inflammation and cancer (2002) · cites this paper as [11]
In the citing paper
“Tumour cells produce various cytokines and chemokines that attract leukocytes.”
From Inflammation and cancer (2002) · cites this paper as [11]
In the citing paper
“The Gram-negative bacterium H. pylori is established as a definite carcinogen for the development of gastric cancer — the second most common type of cancer globally11,29 — and DNA damage resulting from chronic inflammation is believed the mechanism32.”
From Inflammation and cancer (2002) · cites this paper as [11]
In the citing paper
“Genetic and functional experiments indicate that neutrophils, mast cells, eosinophils and activated T lymphocytes also contribute to malignancies by releasing extracellular proteases, pro-angiogenic factors and chemokines11,23–26.”
From Inflammation and cancer (2002) · cites this paper as [11]
In the citing paper
“Indeed, there is a growing body of evidence that many malignancies are initiated by infections11,27–29 (Table 1) — upwards of 15% of malignancies worldwide can be attributed to infections, a global total of 1.2 million cases per year11.”
From Inflammation and cancer (2002) · cites this paper as [11]
In the citing paper
“Indeed, there is a growing body of evidence that many malignancies are initiated by infections11,27–29 (Table 1) — upwards of 15% of malignancies worldwide can be attributed to infections, a global total of 1.2 million cases per year11.”
From Inflammation and cancer (2002) · cites this paper as [11]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IARC Monographs on the Evaluation of Carcinogenic Risks to Humans
Zuckerman, A. J. (1995) · Journal of Clinical Pathology · doi:10.1136/jcp.48.7.691-a · Cited by 8,766
The environment and disease: association or causation?
Hill, A. B. (2015) · Journal of the Royal Society of Medicine · doi:10.1177/0141076814562718 · Cited by 7,804
The Environment and Disease: Association or Causation?
Hill, A. B. (1965) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591576505800503 · Cited by 6,974
The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994
Alter, M. J., Kruszon‐Moran, D., Nainan, O. V., McQuillan, G. M., Gao, F., Moyer, L. A., Kaslow, R. A., & Margolis, H. S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908193410802 · Cited by 2,973
HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUS
Beasley, R. P., Lin, C., Hwang, L., & Chien, C. (1981) · The Lancet · doi:10.1016/s0140-6736(81)90585-7 · Cited by 2,856
Association of Human Papillomavirus Types 16 and 18 E6 Proteins with p53
Werness, B. A., Levine, A. J., & Howley, P. M. (1990) · Science · doi:10.1126/science.2157286 · Cited by 2,562
Adult T-cell leukemia: clinical and hematologic features of 16 cases
Uchiyama, T., Yodoi, J., Sagawa, K., Takatsuki, K., & Uchino, H. (1977) · Blood · doi:10.1182/blood.v50.3.481.bloodjournal503481 · Cited by 2,315
Helicobacter pylori Infection and Gastric Lymphoma
Parsonnet, J., Hansen, S., Rodríguez, L. V., Gelb, A. B., Warnke, R. A., Jellum, E., Orentreich∥, N., Vogelman∥, J. H., & FRIEDMAN, G. D. (1994) · New England Journal of Medicine · doi:10.1056/nejm199405053301803 · Cited by 1,826
Miyoshi, I., Kubonishi, I., Yoshimoto, S., Akagi, T., Ohtsuki, Y., Shiraishi, Y., Nagata, K., & Hinuma, Y. (1981) · Nature · doi:10.1038/294770a0 · Cited by 1,402
Papillomaviruses Causing Cancer: Evasion From Host-Cell Control in Early Events in Carcinogenesis
Hausen, H. Z. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.9.690 · Cited by 1,297
Research works printed but not linked: 12
- Parsonnet J., 1999, Microbes and Malignancy., 3
- Zur Hausen H., 1999, Microbes and Malignancy., 107
- IARC, Hepatitis viruses., 1994, IARC monographs on the evaluation of carcinogenic risks to humans.
- Robinson WS., 1999, Microbes and Malignancy., 232
- Chung RT, 1999, Microbes and Malignancy., 267
- IARC, Infections with Epstein–Barr virus, human herpes viruses., 1997, IARC monographs on the evaluation of carcinogenic risks to humans., 70
- Pagona JS., 1975, Cold Spring Harbor Symposium on quantitative biology: tumor viruses, XXIX, 797
- Chang Y., 1999, Microbes and Malignancy., 207
- Newton R, 1999, Infections and Human Cancer., 237
- IARC. Schistosomes, Liver Flukes and Helicobacter Pylori., 1994, Monographs on the Evaluation of Carcinogenic Risks to Humans no. 61.
- Danesh J., 1999, Infections and Human Cancer., 263
- EkströmA‐M.Factors related to the occurence of gastrric adenocarcinoma subtypes.Doctoral Dissertation Stockholm: Karolinska Institutet 2000.
Cited by
Sorted by citations
Items 101–200 of 738
Genetic aspects of inflammation and cancer
Hold, G. L., & El-Omar, E. M. (2008) · Biochemical Journal · doi:10.1042/bj20071341 · Cited by 135
Kasai, C., Sugimoto, K., Moritani, I., Tanaka, J., Oya, Y., Inoue, H., Tameda, M., Shiraki, K., Ito, M., Takei, Y., et al. (2015) · Oncology Reports · doi:10.3892/or.2015.4398 · Cited by 130
Chronic bacterial and parasitic infections and cancer: a review
Samaras, V. D., Rafailidis, P. I., Mourtzoukou, E. G., Peppas, G., & Falagas, M. E. (2010) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.819 · Cited by 131
Oxidative Stress in Fanconi Anemia Hematopoiesis and Disease Progression
Du, W., Ádám, Z., Rani, R., Zhang, X., & Pang, Q. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2008.2129 · Cited by 133
Association of human papillomavirus infection and inflammation in cervical cancer
Hemmat, N., & Baghi, H. B. (2019) · Pathogens and Disease · doi:10.1093/femspd/ftz048 · Cited by 132
The Role of Chronic Inflammation in Obesity-Associated Cancers
Ramos‐Niño, M. E. (2013) · ISRN Oncology · doi:10.1155/2013/697521 · Cited by 137
Guo, Y., Nie, Q. H., MacLean, A. L., Li, Y., Lei, J., & Li, S. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-1662 · Cited by 121
Alteration in Taste Perception in Cancer: Causes and Strategies of Treatment
Murtaza, B., Hichami, A., Khan, A. S., Ghiringhelli, F., & Khan, N. A. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00134 · Cited by 133
Sylman, J. L., Mitrugno, A., Atallah, M. B., Tormoen, G. W., Shatzel, J. J., Yunga, S. T., Wagner, T. H., Leppert, J. T., Mallick, P., & McCarty, O. J. T. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00078 · Cited by 121
p53 and the Carcinogenicity of Chronic InflammationPreprint
Gudkov, A. V., & Komarova, E. A. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026161 · Cited by 126
Pal, S., Bhattacharjee, A., Ali, A., Mandal, N. C., Mandal, S. C., & Pal, M. (2014) · Journal of Inflammation · doi:10.1186/1476-9255-11-23 · Cited by 119
Behavioral interventions to increase HPV vaccination acceptability among mothers of young girls.
Cox, D. S., Cox, A. D., Sturm, L. A., & Zimet, G. D. (2010) · Health Psychology · doi:10.1037/a0016942 · Cited by 114
Fighting Cancer with Red Wine? Molecular Mechanisms of Resveratrol
Kraft, T. E., Parisotto, D. A., Schempp, C. M., & Efferth, T. (2009) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408390802248627 · Cited by 116
Interleukin-6 and its receptor, key players in hepatobiliary inflammation and cancer.
Johnson, C. N., Han, Y., Hughart, N., McCarra, J., Alpini, G. D., & Meng, F. (2012) · PubMed · doi:10.3978/j.issn.2224-4778.2011.11.02 · Cited by 114
Energy‐Converting Nanomedicine
Xiang, H., & Chen, Y. (2019) · Small · doi:10.1002/smll.201805339 · Cited by 114
Eck, M., Schmaußer, B., Scheller, K., Brändlein, S., & Müller‐Hermelink, H. K. (2003) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2003.02305.x · Cited by 113
Pro-inflammatory prostaglandins and progression of colorectal cancer
Wang, D., & DuBois, R. N. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.004 · Cited by 116
Westbrook, A. M., Szakmary, A., & Schiestl, R. H. (2010) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2010.03.001 · Cited by 113
Soluble Mediators of Inflammation During Tumor Development
Robinson, S. C., & Coussens, L. M. (2005) · Advances in cancer research · doi:10.1016/s0065-230x(05)93005-4 · Cited by 112
Inflammatory Mediators in Oral Cancer: Pathogenic Mechanisms and Diagnostic Potential
Niklander, S. E. (2021) · Frontiers in Oral Health · doi:10.3389/froh.2021.642238 · Cited by 122
Infectious and dietary risk factors of oral cancer
Meurman, J. H. (2010) · Oral Oncology · doi:10.1016/j.oraloncology.2010.03.003 · Cited by 109
COX-2 and PGE2-dependent immunomodulation in breast cancer
Chen, E. P., & Smyth, E. M. (2011) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2011.08.005 · Cited by 114
Assembly of Inflammation-Related Genes for Pathway-Focused Genetic Analysis
Loza, M. J., McCall, C. E., Li, L., Isaacs, W. B., Xu, J., & Chang, B. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001035 · Cited by 107
Pal, R., Chakraborty, B., Nath, A., Singh, L. M., Ali, M. A., Rahman, D. S., Ghosh, S. K., Basu, A., Bhattacharya, S., Baral, R., et al. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.06.006 · Cited by 110
Ando, M., Uehara, I., Kogure, K., Asano, Y., Nakajima, W., Abe, Y., Kawauchi, K., & Tanaka, N. (2010) · Journal of Nippon Medical School · doi:10.1272/jnms.77.97 · Cited by 107
The inflammatory network in the gastrointestinal tumor microenvironment: lessons from mouse models
Oshima, H., & Oshima, M. (2012) · Journal of Gastroenterology · doi:10.1007/s00535-011-0523-6 · Cited by 105
Gallagher, P. G., Bao, Y., Prorock, A. J., Zigrino, P., Nischt, R., Politi, V., Mauch, C., Dragulev, B. P., & Fox, J. W. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-0415 · Cited by 105
“Potential Health Benefits of Lunasin: A Multifaceted Soy‐Derived Bioactive Peptide”
Lule, V. K., Garg, S., Pophaly, S. D., Hitesh, H., & Tomar, S. K. (2015) · Journal of Food Science · doi:10.1111/1750-3841.12786 · Cited by 109
Abu-Remaileh, M., Bender, S., Raddatz, G., Ansari, I., Cohen, D., Gutekunst, J., Musch, T., Linhart, H., Breiling, A., Pikarsky, E., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3295 · Cited by 102
Philpott, M., & Ferguson, L. (2004) · Mutation research · doi:10.1016/j.mrfmmm.2004.03.005 · Cited by 106
Role of infectious agents in the carcinogenesis of brain and head and neck cancers
Alibek, K., Kakpenova, A., & Baiken, Y. (2013) · Infectious Agents and Cancer · doi:10.1186/1750-9378-8-7 · Cited by 100
Stem cells and cancer: Evidence for bone marrow stem cells in epithelial cancers
Li, H., Stoicov, C., Rogers, A. B., & Houghton, J. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i3.363 · Cited by 102
Sabaawy, H. E., Ryan, B. M., Khiabanian, H., & Pine, S. R. (2021) · Carcinogenesis · doi:10.1093/carcin/bgab075 · Cited by 106
ASSOCIATION OF PARASITIC INFECTIONS AND CANCERS
Khurana, S., Dubey, M., & Malla, N. (2005) · Indian Journal of Medical Microbiology · doi:10.1016/s0255-0857(21)02644-x · Cited by 98
Inflammation and Cancer: When NF-κB Amalgamates the Perilous Partnership
Dobrovolskaia, M. A., & Kozlov, S. (2005) · Current Cancer Drug Targets · doi:10.2174/1568009054629645 · Cited by 96
Inflammation in prostate cancer progression and therapeutic targeting.
Stark, T., Livas, L. I., & Kyprianou, N. (2015) · PubMed Central · doi:10.3978/j.issn.2223-4683.2015.04.12 · Cited by 100
Chen, Z., Wang, K., Lü, H., Xue, D., Fan, M., Zhuang, Q., Yin, S., He, X., & Xu, R. (2019) · Cancer Management and Research · doi:10.2147/cmar.s186976 · Cited by 98
Wolf, A., Moissl‐Eichinger, C., Perras, A., Koskinen, K., Tomazic, P. V., & Thurnher, D. (2017) · Scientific Reports · doi:10.1038/s41598-017-06361-2 · Cited by 98
The microbiome and lung cancer
Maddi, A., Sabharwal, A., Violante, T., Manuballa, S., Genco, R. J., Patnaik, S. K., & Yendamuri, S. (2019) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.12.88 · Cited by 95
Bladder cancer and schistosomiasis
Zaghloul, M. S. (2012) · Journal of the Egyptian National Cancer Institute · doi:10.1016/j.jnci.2012.08.002 · Cited by 94
Yang, C., Hsieh, S.-L., Ho, F., & Lin, W. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.3.1647 · Cited by 92
Inducible Nitric Oxide Synthase in the Carcinogenesis of Gastrointestinal Cancers
de Oliveira, G. A., Cheng, R. Y. S., Ridnour, L. A., Basudhar, D., Somasundaram, V., McVicar, D. W., Monteiro, H. P., & Wink, D. A. (2017) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6850 · Cited by 91
Costs of detection and treatment of cervical cancer, cervical dysplasia and genital warts in the UK
Brown, R. E., Breugelmans, J. G., Theodoratou, D., & Bénard, S. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x99972 · Cited by 90
Hoejberg, L., Bastholt, L., & Schmidt, H. (2012) · Melanoma research · doi:10.1097/cmr.0b013e3283543d72 · Cited by 87
Role of toll-like receptors in tissue repair and tumorigenesis
Rakoff-Nahoum, S., & Medzhitov, R. M. (2008) · Biochemistry (Moscow) · doi:10.1134/s0006297908050088 · Cited by 91
Eicosanoids in inflammation and cancer: the role of COX-2
Agarwal, S., Reddy, G. V., & Reddanna, P. (2009) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.5.2.145 · Cited by 91
Role of infectious diseases in human carcinogenesis
Herrera, L. A., Benı́tez-Bribiesca, L., Mohar, A., & Ostrosky‐Wegman, P. (2005) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20122 · Cited by 88
Inflammation in multimorbidity and disability: An integrative review.
Friedman, E. M., & Shorey, C. (2019) · Health Psychology · doi:10.1037/hea0000749 · Cited by 119
Underlying Causes and Therapeutic Targeting of the Inflammatory Tumor Microenvironment
Comen, E. A., Bowman, R. L., & Kleppe, M. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00056 · Cited by 87
The Role of IL-33-Dependent Inflammation in the Tumor Microenvironment
Wasmer, M.-H., & Krebs, P. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00682 · Cited by 84
Islam, S. U., Lee, J., Shehzad, A., Ahn, E., Lee, Y. J., & Lee, Y. K. (2018) · Molecules · doi:10.3390/molecules23081880 · Cited by 84
Chen, M., Gu, Y.-Y., Zhang, A. L., Sze, D., Mo, S., & May, B. H. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105778 · Cited by 83
Guadagni, F., Ferroni, P., Palmirotta, R., Portarena, I., Formica, V., & Roselli, M. (2007) · PubMed · Cited by 82
The Inflammatory Tumor Microenvironment, Epithelial Mesenchymal Transition and Lung Carcinogenesis
Heinrich, E. L., Walser, T. C., Krysan, K., Liclican, E. L., Grant, J. L., Rodriguez, N., & Dubinett, S. M. (2011) · Cancer Microenvironment · doi:10.1007/s12307-011-0089-0 · Cited by 87
Ellem, S. J., Wang, H., POUTANEN, M. H., & Risbridger, G. P. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.081107 · Cited by 82
Zhou, L., Ding, L., Yin, P., Lu, X., Wang, X., Niu, J., Gao, P., & Xu, G. (2012) · Journal of Proteome Research · doi:10.1021/pr300683a · Cited by 82
Exploring the immunomodulatory and anticancer properties of zerumbone
Haque, M. A., Jantan, I., Arshad, L., & Bukhari, S. N. A. (2017) · Food & Function · doi:10.1039/c7fo00595d · Cited by 82
Protocol of the European Registry on the management of Helicobacter pylori infection (Hp‐EuReg)
McNicholl, A. G., O'Morain, C. A., Mégraud, F., & Gisbert, J. P. (2019) · Helicobacter · doi:10.1111/hel.12630 · Cited by 89
The Role of Helminth Infections in Carcinogenesis
Mayer, D. A., & Fried, B. N. (2007) · Advances in Parasitology/Advances in parasitology · doi:10.1016/s0065-308x(07)65004-0 · Cited by 82
Tissue Involution and the Acute Phase Response
Nilsen‐Hamilton, M., LIU, Q., Ryon, J., Bendickson, L., Lepont, P., & Chang, Q. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb03213.x · Cited by 81
COX-2-PGE2-EPs in gynecological cancers
Yao, Y., Wang, X., Jeschke, U., & von Schönfeldt, V. (2020) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-020-05559-6 · Cited by 85
A new classification for potentially malignant disorders of the oral cavity
Sarode, S. C., Sarode, G. S., Karmarkar, S., & Tupkari, J. V. (2011) · Oral Oncology · doi:10.1016/j.oraloncology.2011.06.005 · Cited by 78
Research Progress on Tumor‐Associated Macrophages and Inflammation in Cervical Cancer
Liu, Y., Li, L., Li, Y., & Zhao, X. (2020) · BioMed Research International · doi:10.1155/2020/6842963 · Cited by 78
Madhusudhan, N., Pausan, M.-R., Halwachs, B., Durdević, M., Windisch, M., Kehrmann, J., Patra, V., Wolf, P., Boukamp, P., Moissl‐Eichinger, C., et al. (2020) · Cancers · doi:10.3390/cancers12030541 · Cited by 81
Role of TLR2‐dependent inflammation in metastatic progression
Kim, S.-H., & Karin, M. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05882.x · Cited by 78
Colon cancer stem cells: implications for prevention and therapy
Huang, E. H., & Wicha, M. S. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.09.005 · Cited by 77
Infection with the carcinogenic human liver fluke, Opisthorchis viverrini
Smout, M. J., Sripa, B., Laha, T., Mulvenna, J. P., Gasser, R. B., Young, N. D., Bethony, J. M., Brindley, P. J., & Loukas, A. C. (2011) · Molecular BioSystems · doi:10.1039/c0mb00295j · Cited by 77
Lu, R., Bosland, M., Xia, Y., Zhang, Y.-G., Kato, I., & Sun, J. (2017) · Oncotarget · doi:10.18632/oncotarget.19052 · Cited by 75
Functional Regulation of Phospholipase D Expression in Cancer and Inflammation
Kang, D. W., Choi, K. Y., & Min, D. S. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.r114.569822 · Cited by 77
Periodontal disease may associate with breast cancer
Söder, B., Yakob, M., Meurman, J. H., Andersson, L. C., Klinge, B., & Söder, P. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1221-4 · Cited by 75
Zijlstra, A., Seandel, M., Kupriyanova, T. A., Partridge, J. J., Madsen, M. A., Hahn-Dantona, E. A., Quigley, J. P., & Deryugina, E. I. (2005) · Blood · doi:10.1182/blood-2005-04-1458 · Cited by 76
Inflammation in Prostatic Hyperplasia and Carcinoma—Basic Scientific Approach
Krušlin, B., Tomas, D., Dzombeta, T. R., Periša, M. M., & Ulamec, M. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00077 · Cited by 75
Molecular concept in human oral cancer
Singh, S., Krishna, A., Kumar, V., & Pal, U. S. (2015) · National Journal of Maxillofacial Surgery · doi:10.4103/0975-5950.168235 · Cited by 77
Fujiwara, N., Kitamura, N., Yoshida, K., Yamamoto, T., Ozaki, K., & Kudo, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176207 · Cited by 73
Immune cells: plastic players along colorectal cancer progression
Caro, G. D., Marchesi, F., Laghi, L., & Grizzi, F. (2013) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12117 · Cited by 74
Khan, S., Imran, A., Khan, A. A., Kalam, M. A., & Alshamsan, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148530 · Cited by 73
A Natural History of Actinic Keratosis and Cutaneous Squamous Cell Carcinoma Microbiomes
Wood, D., Lachner, N., Tan, J. M., Tang, S. J., Angel, N. Z., Laino, A. M., Linedale, R., Cao, K. L., Morrison, M., Frazer, I. H., et al. (2018) · mBio · doi:10.1128/mbio.01432-18 · Cited by 78
Transcriptional Regulation during Aberrant Activation of NF-κB Signalling in Cancer
Deka, K., & Li, Y. (2023) · Cells · doi:10.3390/cells12050788 · Cited by 75
Chronic inflammation and gallbladder cancer
Li, Y., Zhang, J., & Ma, H. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.08.034 · Cited by 72
Antihistamines as promising drugs in cancer therapy
Faustino‐Rocha, A. I., Ferreira, R. M., Gama, A., Oliveira, P. A., & Ginja, M. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.12.008 · Cited by 71
Pierce, E. S. (2018) · Infectious Agents and Cancer · doi:10.1186/s13027-017-0172-3 · Cited by 71
Focal infection: new age or ancient history?
Pallasch, T. J., & Wahl, M. J. (2003) · Endodontic Topics · doi:10.1034/j.1601-1546.2003.00002.x · Cited by 71
Honey and Cancer: Sustainable Inverse Relationship Particularly for Developing Nations—A Review
Othman, N. H. (2012) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/410406 · Cited by 69
Oral cancer associated with chronic mechanical irritation of the oral mucosa
Piemonte, E. D., Lazos, J. P., Belardinelli, P., Secchi, D. G., Brunotto, M. N., & Lanfranchi, H. E. (2018) · Medicina oral, patología oral y cirugía bucal · doi:10.4317/medoral.22017 · Cited by 69
Allendorf, D. J., Yan, J., Ross, G. D., Hansen, R., Baran, J. T., Subbarao, K., Wang, L., & Haribabu, B. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.11.7050 · Cited by 68
HDAC inhibitors in models of inflammation-related tumorigenesis
Glauben, R., Sonnenberg, E., Zeitz, M., & Siegmund, B. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.11.019 · Cited by 67
The relationship between previous pulmonary tuberculosis and risk of lung cancer in the future
Qin, Y., Chen, Y., Chen, J., Xu, K., Xu, F., & Shi, J. (2022) · Infectious Agents and Cancer · doi:10.1186/s13027-022-00434-2 · Cited by 65
Dietary Cancer Chemopreventive Agents – Targeting Inflammation and Nrf2 Signaling Pathway
Khor, T. O., Yu, S., & Kong, A. T. (2008) · Planta Medica · doi:10.1055/s-0028-1088303 · Cited by 64
Inflammation and Stem Cells in Gastrointestinal Carcinogenesis
Quante, M., & Wang, T. C. (2008) · Physiology · doi:10.1152/physiol.00031.2008 · Cited by 64
From Inflammation to Prostate Cancer: The Role of Inflammasomes
Karan, D., & Dubey, S. (2016) · Advances in Urology · doi:10.1155/2016/3140372 · Cited by 64
Genomics and proteomics approaches to the study of cancer-stroma interactions
Rodrigues‐Lisoni, F. C., Peitl, P., Vidotto, A., Polachini, G. M., Maniglia, J. V., Carmona-Raphe, J., da Cunha, B. R., Henrique, T., Souza, C. F., Teixeira, R. S. V., et al. (2010) · BMC Medical Genomics · doi:10.1186/1755-8794-3-14 · Cited by 63
STEWART, S. L., Kwong, S. L., Bowlus, C. L., Nguyen, T. T., Maxwell, A. E., Bastani, R., Chak, E., & Chen, M. S. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i38.8584 · Cited by 63
Clinical Significance of Preoperative Inflammatory Parameters in Gastric Cancer Patients
Lee, D. Y., Hong, S. W., Chang, Y. G., Lee, W. Y., & Lee, B.-M. (2013) · Journal of the Korean Gastric Cancer Association · doi:10.5230/jgc.2013.13.2.111 · Cited by 62
Bhattacharyya, M., Jariyal, H., & Srivastava, A. (2023) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2023.121081 · Cited by 62
Lee, Y. A., Yun, B. H., Kim, S. K., Margolin, Y., Dedon, P. C., Geacintov, N. E., & Shafirovich, V. (2007) · Chemistry - A European Journal · doi:10.1002/chem.200601434 · Cited by 62
Medical history, sexual, and maturational factors and prostate cancer risk
Lightfoot, N., Conlon, M., Kreiger, N., SASS-KORTSAK, A. M., Purdham, J. T., & Darlington, G. (2004) · Annals of Epidemiology · doi:10.1016/j.annepidem.2003.11.006 · Cited by 62
DNA Damage: From Chronic Inflammation to Age-Related Deterioration
Ιωαννίδου, Ά., Goulielmaki, E., & Garinis, G. A. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2016.00187 · Cited by 62
Thurner, E.-M., Krenn-Pilko, S., Langsenlehner, U., Stojaković, T., Pichler, M., Gerger, A., Kapp, K. S., & Langsenlehner, T. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2015.01.002 · Cited by 61
Wu, Q., Li, M., Tan, L., Yu, J., Chen, Z., Su, L., Ren, X., Fu, C., Ren, J., Li, L., et al. (2018) · Nanoscale Horizons · doi:10.1039/c8nh00113h · Cited by 61
Persistent Infection with Helicobacter Pylori and the Development of Gastric Cancer
Normark, S. J., Nilsson, C., Normark, B. H., & Hornef, M. W. (2003) · Advances in cancer research · doi:10.1016/s0065-230x(03)90002-9 · Cited by 61
Metadata
- Authors
- Kuper, H., Adami, H. ‐., & Trichopoulos, D.
- Affiliations
- Harvard University (US)
- Venue
- Journal of Internal Medicine
- Publisher
- Wiley
- Published
- 2000-09
- Volume
- 248
- Issue
- 3
- Pages
- 171-183
- ISSN
- 0954-6820 (ISSN-L)
- 1365-2796
- OpenAlex
- W2159454395
- Cited by
- 740
- References
- 109
- Citations by year
- 2026: 3 · 2025: 14 · 2024: 23 · 2023: 44 · 2022: 29 · 2021: 39 · 2020: 36 · 2019: 42 · 2018: 32 · 2017: 41 · 2016: 35 · 2015: 37 · 2014: 32 · 2013: 44 · 2012: 30
- FWCI
- 0.85
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
- Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
- Health Sciences › Medicine › Otorhinolaryngology › Head and Neck Cancer Studies
- Keywords
- infection, cancer prevention, carcinogenesis, chronic inflammation, oncogenes, tumour suppressor, immunosuppression, persistent infection, tumor latency
- MeSH terms
- Animals, Clonorchiasis, Humans, Neoplasms, Primary Prevention, Schistosomiasis, Virus Diseases, Helicobacter pylori, Helicobacter Infections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
